Cargando…
The cardiovascular impact of visfatin - an inflammation predictor biomarker in metabolic syndrome
As it had been already stated by latest research, inflammation is a condition which sits at the very base of atherogenesis, which is the major consequence of the metabolic syndrome. It was stated that adipose tissue impacts all organs by the synthesis of adipokines. Visfatin/NAMPT is a biomarker tha...
Autores principales: | HOGNOGI, LARISA DIANA MOCAN, SIMITI, LUMINITA VIDA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990425/ https://www.ncbi.nlm.nih.gov/pubmed/27547049 http://dx.doi.org/10.15386/cjmed-591 |
Ejemplares similares
-
Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020) -
Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
por: Mocan, Mihaela, et al.
Publicado: (2019) -
Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
por: Mocan Hognogi, Larisa-Diana, et al.
Publicado: (2018) -
Hemodynamic monitoring using thoracic bioimpedance – an optimal solution for the treatment of hypertension
por: FARCAS, ANCA DANIELA, et al.
Publicado: (2018) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013)